mRNA-1345 Demonstrates Consistent Vaccine Efficacy in Older Adults Aged ≥60 Years at High Risk of RSV Disease

Mihir Desai, Christopher Duncan, Priyantha Wijewardane, Emily Comstock, Lan Lan, Shraddha Mehta, Frances Priddy

Thursday 19 February 2026

Safety, Tolerability, and Immunogenicity of the mRNA-1345 RSV Vaccine in Solid Organ Transplant Recipients Aged ≥18 Years

Erick F. Mayer, Ann R. Falsey, Cameron R. Wolfe, Erica Herc, Fiona Burns, Dima Kabbani, Deepali Kumar, Christina Grassi, Avi Collins, Anisha Mannan, Joseph Whitten, Anthony Rizk, Caroline Reuter, Archana Kapoor, Sonia K. Stoszek, Jiejun Du, Jenni Mou, Lan Lan, Honghong Zhou, Eleanor Wilson, Jaya Goswami, Rituparna Das, Frances Priddy
Non-author presenter: Mihir Desai

Thursday, 19 February 2026

Modeling the Public Health Impact of RSV Vaccination in US Adults Aged ≥60 Years Using Real-World Effectiveness Data

Katherine Hicks, Ziyi Xiao, Weijie Zhang, Elissa Wilker, Chris Clarke, Parinaz Ghwaswalla

Friday, 20 February 2026